SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-066648
Filing Date
2017-11-07
Accepted
2017-11-07 16:32:37
Documents
44
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20627_110q.htm 10-Q 728976
2 EX-31.1 a17-20627_1ex31d1.htm EX-31.1 11435
3 EX-32.1 a17-20627_1ex32d1.htm EX-32.1 5569
  Complete submission text file 0001104659-17-066648.txt   3332053

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT espr-20170930.xml EX-101.INS 691496
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20170930.xsd EX-101.SCH 24247
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20170930_cal.xml EX-101.CAL 34772
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20170930_lab.xml EX-101.LAB 294775
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20170930_pre.xml EX-101.PRE 192325
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20170930_def.xml EX-101.DEF 101697
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 171183795
SIC: 2834 Pharmaceutical Preparations